13F filer · CIK 914208 ↗
Invesco Ltd.
You are looking at Q2 2016. See the latest, Q2 2026 →
Reported value
$272.23B
+11% on the quarter before
Positions
3,680
166 new · 185 sold out
Top 10
15.7%
of the value
Est. gain
+$3.90B
on stocks held all quarter
Est. return
+1.8%
on those stocks since Q1 2016
Positions as of Jun 30, 2016, from Invesco Ltd.'s 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 26% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2016. Striped tiles are options.
Largest buys
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Royal Bk Of Scotland Plc~$9.18BNew · 0.0% → 3.4%+98,400,000 shares
- Royal Bk Of Scotland Plc~$8.56BNew · 0.0% → 3.1%+93,590,000 shares
- Hsbc Hldgs Plc~$2.59BNew · 0.0% → 1.0%+27,194,000 shares
- Standard Chartered Plc~$2.48BNew · 0.0% → 0.9%+27,000,000 shares
- Lloyds Banking Group Plc~$2.12BNew · 0.0% → 0.8%+21,665,000 shares
- Charter Communications Inc N~$858.0MNew · 0.0% → 0.3%+3,752,632 shares
- Barclays Plc~$733.1MNew · 0.0% → 0.3%+7,500,000 shares
- Barclays Plc~$714.0MNew · 0.0% → 0.3%+8,000,000 shares
- Hsbc Hldgs Plc~$447.8MNew · 0.0% → 0.2%+4,500,000 shares
- S&P Global Inc~$270.9MNew · 0.0% → 0.1%+2,525,739 shares
Largest sells
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$911.1MCut · 2.5% → 1.7%−9,530,217 shares
- Time Warner Cable Inc~$673.7MSold out · 0.3% → 0.0%−3,292,309 shares
- Amazon~$502.6MCut · 1.3% → 1.2%−702,375 shares
- Microsoft~$376.1MCut · 2.2% → 1.7%−7,350,708 shares
- Mcgraw Hill Finl Inc~$246.0MSold out · 0.1% → 0.0%−2,485,467 shares
- Meta~$226.0MCut · 1.2% → 1.0%−1,977,411 shares
- General Electric Co~$225.1MCut · 0.6% → 0.5%−7,151,186 shares
- Gilead Sciences Inc~$216.1MCut · 0.8% → 0.6%−2,590,417 shares
- Alphabet~$208.8MCut · 1.0% → 0.7%−301,699 shares
- Teva Pharmaceutical Inds Ltd~$204.8MCut · 0.4% → 0.3%−4,077,251 shares
Holdings
As of Jun 30, 2016. Changes are in shares against Mar 31, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Royal Bk Of Scotland PlcNOTE 8.000%12/3 · shares New | 3.4% | $9.18B | — | ||||||||
| Royal Bk Of Scotland PlcDEBT 7.500%12/3 · shares New | 3.1% | $8.56B | — | ||||||||
| MicrosoftCOM · shares −7.7% · price −7.4% | 1.7% | $4.53B | −$359.1M | ||||||||
| AppleCOM · shares −17% · price −12.3% | 1.7% | $4.50B | −$630.1M | ||||||||
| AmazonCOM · shares −14% · price +20.5% | 1.2% | $3.21B | +$547.8M | ||||||||
| MetaCL A · shares −7.5% · price +0.2% | 1.0% | $2.80B | +$4.4M | ||||||||
| Ing Groep N VDBCV 6.500%12/2 · shares 0% · price −0.2% | 0.96% | $2.61B | — | ||||||||
| Hsbc Hldgs PlcNOTE 6.375%12/2 · shares New | 0.95% | $2.59B | — | ||||||||
| Standard Chartered PlcDEBT 6.500%12/2 · shares New | 0.91% | $2.48B | — | ||||||||
| Comcast Corp NewCL A · shares −5.9% · price +6.7% | 0.88% | $2.39B | +$150.8M | ||||||||
| AlphabetCAP STK CL A · shares −7.3% · price −7.8% | 0.87% | $2.38B | −$200.6M | ||||||||
| CiscoCOM · shares −4.6% · price +0.8% | 0.87% | $2.36B | +$18.1M | ||||||||
| Jpmorgan Chase & CoCOM · shares −0.5% · price +4.9% | 0.84% | $2.28B | +$106.9M | ||||||||
| Simon Ppty Group Inc NewCOM · shares −4.8% · price +4.4% | 0.80% | $2.18B | +$92.7M | ||||||||
| Citigroup IncCOM NEW · shares +0.3% · price +1.5% | 0.79% | $2.16B | +$32.5M | ||||||||
| Lloyds Banking Group PlcSDCV 7.500%12/3 · shares New | 0.78% | $2.12B | — | ||||||||
| IntelCOM · shares −3.9% · price +1.4% | 0.76% | $2.06B | +$28.3M | ||||||||
| AlphabetCAP STK CL C · shares −9.3% · price −7.1% | 0.75% | $2.04B | −$155.5M | ||||||||
| Reynolds American IncCOM · shares −9.0% · price +7.2% | 0.74% | $2.03B | +$136.0M | ||||||||
| Ing Groep N VDBCV 6.000%12/2 · shares 0% · price +0.5% | 0.74% | $2.01B | — | ||||||||
| Gilead Sciences IncCOM · shares −12% · price −9.2% | 0.57% | $1.56B | −$158.2M | ||||||||
| Amgen IncCOM · shares −5.2% · price +1.5% | 0.57% | $1.56B | +$22.7M | ||||||||
| Pfizer IncCOM · shares −7.6% · price +18.8% | 0.56% | $1.51B | +$239.3M | ||||||||
| Merck & Co IncCOM · shares −2.0% · price +8.9% | 0.53% | $1.45B | +$118.4M | ||||||||
| Walgreens Boots Alliance IncCOM · shares +11% · price −1.2% | 0.51% | $1.38B | −$14.5M | ||||||||
| Total · 3,680 positions | 100% | $272.23B | +$3.90B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2016 to Q2 2016: 3,361 stocks held throughout, up $3.90B (+1.8%).
- Amazon+$547.8M+21%
- Netease Inc+$304.5M+35%
- Pfizer Inc+$239.3M+19%
- Devon Energy Corp New+$222.0M+32%
- Comcast Corp New+$150.8M+7%
- Alphabet−$200.6M−8%
- Baidu−$203.2M−13%
- Carnival Corp−$214.3M−16%
- Microsoft−$359.1M−7%
- Apple−$630.1M−12%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $1.26T+23% | SEC ↗ |
| Q1 2026 | May 12, 2026 (amended) | $1.02T−3% | SEC ↗ |
| Q4 2025 | Feb 19, 2026 (amended) | $1.06T+67% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $634.72B+8% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $587.99B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $527.93B−2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $540.90B+4% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $517.95B+10% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $472.84B+2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $465.56B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $420.24B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $371.30B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $381.45B+6% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $358.48B+5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $341.42B+10% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $310.69B−6% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $330.04B−16% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $392.05B−5% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $414.84B+5% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $394.59B−3% | SEC ↗ |
| Q2 2021 | Aug 17, 2021 | $406.58B+9% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $374.71B+9% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $343.59B+16% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $295.82B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $279.68B+18% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $237.58B−26% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $322.08B−16% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $382.36B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 (amended) | $388.53B+31% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $296.53B+14% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $261.24B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $317.79B+5% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $302.15B+13% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $267.56B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $277.31B+2% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.72B−16% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $321.34B+5% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $304.59B+2% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $297.54B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $291.04B+7% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $272.23B+11% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $246.04B | SEC ↗ |